This topic contains a solution. Click here to go to the answer

Author Question: The hormone that dominates during the alarm phase of the general adaptation syndrome (GAS) is A) ... (Read 59 times)

scienceeasy

  • Hero Member
  • *****
  • Posts: 565
The hormone that dominates during the alarm phase of the general adaptation syndrome (GAS) is
 A) testosterone.
  B) aldosterone.
  C) cortisol.
  D) thyroid hormone.
  E) epinephrine.

Question 2

The end products of aerobic respiration are
 A) carbon dioxide, water, and ATP.
  B) pyruvic acid and carbon dioxide.
  C) carbon dioxide and alcohol.
  D) oxygen and water.
  E) NADH and FADH2.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

xiaomengxian

  • Sr. Member
  • ****
  • Posts: 311
Answer to Question 1

E

Answer to Question 2

A




scienceeasy

  • Member
  • Posts: 565
Reply 2 on: Feb 28, 2019
Wow, this really help


brbarasa

  • Member
  • Posts: 308
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Long-term mental and physical effects from substance abuse include: paranoia, psychosis, immune deficiencies, and organ damage.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

There are actually 60 minerals, 16 vitamins, 12 essential amino acids, and three essential fatty acids that your body needs every day.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library